roche glp-1 drug Weighs In With Encouraging Early Clinical Data for Oral Roche, trailing in obesity, showcases
Description
The medication, sold under the name Mounjaro, will be available in six different doses and come in an auto-injector pen.
2026 is likely the year that two new oral weight loss drugs from Novo Nordisk and Eli Lilly will reach patients in the U.S.
Includes: HG Shampoo (10.14 fl oz.)
Source in comments.
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), approved for diabetes and obesity, have shown promise in modulating reward-related brain pathways, suggesting potential benefits in the management of AUD
